Dishman Carbogen Amcis
Dishman Carbogen Amcis Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Dishman Carbogen Amcis
Start SIPDishman Carbogen Amcis Investment Rating
-
Master Rating:
-
Dishman Carbogen Amcis has an operating revenue of Rs. 2,363.35 Cr. on a trailing 12-month basis. An annual revenue growth of 12% is good, Pre-tax margin of 0% needs improvement, ROE of 0% is poor and needs improvement. The company has a reasonable debt to equity of 14%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 25% and 20% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 30 which is a POOR score indicating inconsistency in earnings, a RS Rating of 81 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 88 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 78 | 107 | 104 | 83 |
| Operating Expenses Qtr Cr | 82 | 105 | 101 | 82 |
| Operating Profit Qtr Cr | -3 | 1 | 3 | 1 |
| Depreciation Qtr Cr | 3 | 35 | 35 | 34 |
| Interest Qtr Cr | 15 | 14 | 13 | 10 |
| Tax Qtr Cr | -4 | -10 | -15 | -38 |
| Net Profit Qtr Cr | -7 | -17 | -25 | 5 |
Dishman Carbogen Amcis Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- 122.24
- 50 Day
- 110.53
- 100 Day
- 106.68
- 200 Day
- 114.89
- 20 Day
- 123.78
- 50 Day
- 103.36
- 100 Day
- 100.78
- 200 Day
- 107.27
Dishman Carbogen Amcis Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 133.44 |
| Second Resistance | 138.22 |
| Third Resistance | 141.94 |
| RSI | 68.8 |
| MFI | 73.52 |
| MACD Single Line | 8.41 |
| MACD | 8.17 |
| Support | |
|---|---|
| First Resistance | 124.94 |
| Second Resistance | 121.22 |
| Third Resistance | 116.44 |
Dishman Carbogen Amcis Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 1,260,644 | 34,188,665 | 27.12 |
| Week | 760,976 | 28,711,609 | 37.73 |
| 1 Month | 1,816,270 | 59,700,792 | 32.87 |
| 6 Month | 859,425 | 35,777,848 | 41.63 |
Dishman Carbogen Amcis Result Highlights
Dishman Carbogen Amcis Synopsis
NSE-Medical-Diversified
Dishman Carbogen Amc is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 302.79 Cr. and Equity Capital is Rs. 31.36 Cr. for the Year ended 31/03/2022. Dishman Carbogen Amcis Ltd. is a Public Limited Listed company incorporated on 17/07/2007 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L74900GJ2007PLC051338 and registration number is 051338.| Market Cap | 2,078 |
| Sales | 372 |
| Shares in Float | 6.43 |
| No of funds | 53 |
| Yield |
| Book Value | 0.49 |
| U/D Vol ratio | 2.2 |
| LTDebt / Equity | 3 |
| Alpha | -0.11 |
| Beta | 1.11 |
Dishman Carbogen Amcis
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 59.32% | 59.32% | 59.32% | |
| Mutual Funds | 3.63% | 4.26% | 6.54% | |
| Foreign Portfolio Investors | 7.2% | 6.2% | 5.85% | |
| Individual Investors | 25.65% | 25.85% | 23.72% | |
| Others | 4.2% | 4.37% | 4.57% |
Dishman Carbogen Amcis Management
| Name | Designation |
|---|---|
| Mr. Janmejay R Vyas | Chairman |
| Mr. Arpit J Vyas | Global Managing Director |
| Mrs. Deohooti J Vyas | Whole Time Director |
| Mr. Sanjay S Majmudar | Independent Director |
| Mr. Ashok C Gandhi | Independent Director |
| Mr. Rajendra S Shah | Independent Director |
| Mr. Subir Kumar Das | Independent Director |
| Mr. Maitri K Mehta | Director |
Dishman Carbogen Amcis Forecast
Price Estimates
Dishman Carbogen Amcis FAQs
What is Share Price of Dishman Carbogen Amcis ?
Dishman Carbogen Amcis share price is ₹132 As on 22 March, 2023 | 01:39
What is the Market Cap of Dishman Carbogen Amcis ?
The Market Cap of Dishman Carbogen Amcis is ₹2078.2 Cr As on 22 March, 2023 | 01:39
What is the P/E ratio of Dishman Carbogen Amcis ?
The P/E ratio of Dishman Carbogen Amcis is -561.7 As on 22 March, 2023 | 01:39
What is the PB ratio of Dishman Carbogen Amcis ?
The PB ratio of Dishman Carbogen Amcis is 0.4 As on 22 March, 2023 | 01:39